KRISTINE NGUYEN: Open Payments
NPI 1902461189 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,540 in 111 payments from 16 companies in 2025. Trend: 2023 $7,404 · 2024 $7,566 · 2025 $2,540
Food & beverage: $2,425Education: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $402 |
| LEO Pharma Inc. | 23 | $328 |
| ABBVIE INC. | 14 | $309 |
| Galderma Laboratories, L.P. | 8 | $278 |
| Regeneron Healthcare Solutions, Inc. | 9 | $257 |
| Lilly USA, LLC | 9 | $198 |
| Novartis Pharmaceuticals Corporation | 5 | $129 |
| Organon LLC | 6 | $125 |
| Incyte Corporation | 5 | $121 |
| PFIZER INC. | 5 | $117 |
Products named: TREMFYA, ADBRY, DUPIXENT, NEMLUVIO, SKYRIZI, TALTZ, RINVOQ, OPZELURA.
Industry payments across CA — which companies pay providers there.
